This month, Hoosier Cancer Research Network features our member, the University of Wisconsin Carbone Cancer Center, and Christos Kyriakopoulos, MD, associate professor of medicine at the University of Wisconsin School of Medicine and Public Health, and a medical oncologist and researcher at UW Carbone Cancer Center.

Research Interests and Expertise

Dr. Kyriakopoulos is an institutional principal investigator for the HCRN study GU16-257, “Neoadjuvant gemcitabine, cisplatin, plus nivolumab in patients with muscle-invasive bladder cancer with selective bladder sparing.” His research interests include clinical trials in prostate cancer, bladder cancer, and kidney cancer. He is particularly interested in imaging and immunotherapy studies in prostate cancer. He is also the study chair of the national trial EA8153, a study led by the ECOG-ACRIN Cancer Research Group in collaboration with the National Cancer Institute (NCI), that examines the role of chemo-hormonal therapy in patients with metastatic castration-resistant prostate cancer who have already received docetaxel.

Educational Background

• Medical School: Aristotle University of Thessaloniki, Greece
• Residency: Mount Sinai Beth Israel Hospital, New York, NY
• Clinical Fellowship: Jackson Memorial Hospital/Sylvester Comprehensive Cancer Center/University of Miami Miller School of Medicine, Hematology-Oncology
• Research Fellowship: Cleveland Clinic Foundation, Experimental Therapeutics

Little-Known Facts

• I am designing a new house.
• I have flown over the Atlantic 60 times.
• I enjoy cooking.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 210 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 8,500 subjects have participated in Hoosier Cancer Research Network clinical trials.